[go: up one dir, main page]

IL138770A0 - Aerosol composition - Google Patents

Aerosol composition

Info

Publication number
IL138770A0
IL138770A0 IL13877099A IL13877099A IL138770A0 IL 138770 A0 IL138770 A0 IL 138770A0 IL 13877099 A IL13877099 A IL 13877099A IL 13877099 A IL13877099 A IL 13877099A IL 138770 A0 IL138770 A0 IL 138770A0
Authority
IL
Israel
Prior art keywords
particulate material
aerosol composition
mum
propellant
particles
Prior art date
Application number
IL13877099A
Other languages
English (en)
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10829846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138770(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Cardiff filed Critical Univ Cardiff
Publication of IL138770A0 publication Critical patent/IL138770A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL13877099A 1998-04-03 1999-04-01 Aerosol composition IL138770A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9807232.5A GB9807232D0 (en) 1998-04-03 1998-04-03 Aerosol composition
PCT/GB1999/001019 WO1999051205A1 (en) 1998-04-03 1999-04-01 Aerosol composition

Publications (1)

Publication Number Publication Date
IL138770A0 true IL138770A0 (en) 2001-10-31

Family

ID=10829846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13877099A IL138770A0 (en) 1998-04-03 1999-04-01 Aerosol composition

Country Status (17)

Country Link
US (2) US6737044B1 (pt)
EP (1) EP1069887B8 (pt)
JP (1) JP2002510614A (pt)
KR (1) KR20010072563A (pt)
CN (1) CN1215832C (pt)
AT (1) ATE474555T1 (pt)
AU (1) AU761518B2 (pt)
BR (1) BR9909394A (pt)
CA (1) CA2327336C (pt)
DE (1) DE69942606D1 (pt)
ES (1) ES2349184T3 (pt)
GB (1) GB9807232D0 (pt)
ID (1) ID27586A (pt)
IL (1) IL138770A0 (pt)
MX (1) MXPA00009660A (pt)
WO (1) WO1999051205A1 (pt)
ZA (1) ZA200005374B (pt)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
AU2001258585B2 (en) * 2000-05-23 2006-12-21 Glaxo Group Limited Aerosol container for formulations of salmeterol xinafoate
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
US20040081627A1 (en) * 2000-10-09 2004-04-29 Jinks Phillip A Medicinal aerosol formulations
AU2002222304B2 (en) * 2000-12-22 2004-03-18 Glaxo Group Limited Metered dose inhaler for salmeterol xinafoate
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
IL157580A0 (en) * 2001-03-20 2004-03-28 Glaxo Group Ltd Inhalation drug combination
AU2002333644A1 (en) * 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
JP2006509716A (ja) * 2002-03-12 2006-03-23 マイクロドース・テクノロジーズ・インコーポレーテッド 吸入で同時投与した薬剤を特定部位へ届ける方法
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
NZ538965A (en) * 2002-08-21 2006-11-30 Norton Healthcare Ltd Dry powder inhalation compositions
AU2003263077B2 (en) * 2002-09-06 2010-04-29 3M Innovative Properties Company Metering valve for a metered dose inhaler providing consistent delivery
GB0221343D0 (en) * 2002-09-16 2002-10-23 3M Innovative Properties Co Aerosol dispensers and adaptors therefor
US7497214B2 (en) * 2002-09-16 2009-03-03 3M Innovative Properties Company Aerosol dispensers and adaptors therefor
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
EP1607117A4 (en) 2003-03-27 2007-10-24 Bioactis Ltd APPLICATOR FOR POWDER MEDICATION IN THE NOSE CAVE
WO2005000712A1 (en) * 2003-06-24 2005-01-06 Cipla Limited Pharmaceutical dispensing aid
CN1878602A (zh) * 2003-11-28 2006-12-13 三菱化学株式会社 有机化合物微粒的制造方法
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
EP1755720A1 (en) * 2004-05-20 2007-02-28 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
US20060260606A1 (en) * 2005-05-18 2006-11-23 Coifman Robert E Inhalable formulations of amphotericin B and methods and devices for delivery thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
WO2008078730A1 (ja) 2006-12-26 2008-07-03 Translational Research, Ltd. 経鼻投与用製剤
US20080202627A1 (en) * 2007-02-23 2008-08-28 Mas Gregory V Dosing System and Method
EP2230934B8 (en) 2007-12-14 2012-10-24 AeroDesigns, Inc Delivering aerosolizable food products
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
RU2463084C2 (ru) * 2008-03-17 2012-10-10 Дискавери Лабораториз, Инк. Адаптер дыхательного контура и система проксимальной доставки аэрозоля
EP2626098B1 (en) 2008-10-22 2020-08-19 Trudell Medical International Modular aerosol delivery system
PT2410981T (pt) 2009-03-26 2017-05-25 Pulmatrix Inc Formulações em pó seco e métodos para tratar doenças pulmonares
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
AU2010324997A1 (en) 2009-11-24 2012-05-31 Gilead Sciences, Inc. Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
PH12012501114A1 (en) 2010-01-05 2024-06-03 Microdose Therapeutx Inc Inhalation device and method
AR081377A1 (es) 2010-05-10 2012-08-29 Gilead Sciences Inc Compuestos de pirazolopiridina bifuncionales
JP5807058B2 (ja) 2010-05-10 2015-11-10 ギリアード サイエンシーズ， インコーポレイテッド 二機能キノリン誘導体
CN103200938B (zh) 2010-08-30 2018-07-31 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
US20130164338A1 (en) 2010-08-30 2013-06-27 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
RU2640921C2 (ru) 2010-09-29 2018-01-12 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
FR2971772B1 (fr) * 2011-02-17 2013-03-22 Valois Sas Dispositif de distribution de produit fluide.
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
FR2973786B1 (fr) * 2011-04-06 2014-07-04 Valois Sas Bague pour dispositif de distribution de produit fluide.
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
SG11201407867VA (en) 2012-05-29 2014-12-30 Parion Sciences Inc Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
CA2896686A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
WO2014099676A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
NZ709197A (en) 2012-12-17 2020-06-26 Parion Sciences Inc 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
AU2013388034B2 (en) 2013-04-30 2019-08-15 Vectura Inc. Dry powder formulations and methods of use
ES2762806T3 (es) 2014-02-10 2020-05-25 Respivant Sciences Gmbh Tratamiento utilizando estabilizadores de mastocitos para trastornos sistémicos
AU2015213681B2 (en) 2014-02-10 2020-03-12 Respivant Sciences Gmbh Mast cell stabilizers for lung disease treatment
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2015127315A1 (en) 2014-02-20 2015-08-27 Otitopic Inc. Dry powder formulations for inhalation
PL3179986T3 (pl) 2014-07-31 2023-06-26 Vectura Inc. Suche formulacje w proszku do inhalacji
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
CN110139646A (zh) 2016-08-31 2019-08-16 瑞思皮万特科学有限责任公司 用于治疗由特发性肺纤维化引起的慢性咳嗽的色甘酸组合物
EP3522983A4 (en) 2016-10-07 2020-06-03 Respivant Sciences GmbH CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
CN107529499B (zh) * 2017-04-20 2020-06-09 苏州康乐辉医药科技有限公司 一种气雾剂药液浓度稳定装置
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN118695855A (zh) * 2022-01-21 2024-09-24 香港大学 通过单次鼻内施用用于鼻和肺沉积的抗病毒剂的双重靶向粉末制剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046863A1 (de) 1980-12-12 1982-07-22 Robert Bosch Gmbh, 7000 Stuttgart Elektronisch gesteuertes kraftstoffzumesssystem fuer eine brennkraftmaschine
GB8613811D0 (en) 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
JPH05508616A (ja) * 1989-02-23 1993-12-02 ローヌー　プーラン　ローラー　インターナショナル（ホウルディングス）インコーポレイテッド 治療用エアロゾル剤
CH680263A5 (pt) 1989-07-20 1992-07-31 Norman Godin
DK0536235T3 (da) 1990-06-29 1997-04-14 Fisons Plc Under tryk stående aerosolpræparater
CA2094266C (en) 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0561166A1 (de) 1992-03-17 1993-09-22 ASTA Medica Aktiengesellschaft Dosieraerosole enthaltend den Wirkstoff D-18024 und verwandte Strukturen
ATE204750T1 (de) * 1992-06-12 2001-09-15 Teijin Ltd Pharmazeutische zubereitung zur anwendung in den atemwegen
WO1994021229A1 (en) * 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
GB9419269D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Aerosol
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB2307842A (en) 1995-12-05 1997-06-11 Lin Chan Yen Ventilated protective helmet
RU2101054C1 (ru) 1996-04-30 1998-01-10 Закрытое акционерное общество "Техно-ТМ" Аэрозолеобразующий состав для тушения пожаров и способ его получения
GB9619968D0 (en) 1996-09-25 1996-11-13 Johnson & Johnson Professional Hinge with locking means
EE200000546A (et) * 1998-03-16 2002-02-15 Inhale Therapeutic Systems, Inc. Aerosoolistatud toimeaine manustamissüsteem
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6136294C1 (en) 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation

Also Published As

Publication number Publication date
CA2327336C (en) 2008-07-08
WO1999051205A1 (en) 1999-10-14
AU3162099A (en) 1999-10-25
GB9807232D0 (en) 1998-06-03
US6737044B1 (en) 2004-05-18
BR9909394A (pt) 2000-12-05
DE69942606D1 (de) 2010-09-02
EP1069887A1 (en) 2001-01-24
JP2002510614A (ja) 2002-04-09
CN1303270A (zh) 2001-07-11
KR20010072563A (ko) 2001-07-31
ATE474555T1 (de) 2010-08-15
EP1069887B1 (en) 2010-07-21
ZA200005374B (en) 2002-01-03
AU761518B2 (en) 2003-06-05
ES2349184T3 (es) 2010-12-28
CA2327336A1 (en) 1999-10-14
US20050249674A1 (en) 2005-11-10
CN1215832C (zh) 2005-08-24
US7481995B2 (en) 2009-01-27
ID27586A (id) 2001-04-12
MXPA00009660A (es) 2003-07-14
EP1069887B8 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
GB9807232D0 (en) Aerosol composition
CA2263445A1 (en) Pharmaceutical aerosol composition
PL348831A1 (en) Improvements in or relating to powders
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
IT1254974B (it) Granulati compositi, scorrevoli,idrofobi,un procedimento per la loro preparazione nonche' loro impiego
AU2221600A (en) Improved expression of hiv polypeptides and production of virus-like particles
EP0812968A3 (en) Insulating construction material
MX9703828A (es) Material mixto que comprende un aerogel, procedimiento para su preparacion, y uso.
AU6690590A (en) An agent for the storage and suspension of cells, especially erythrocytes
MY110500A (en) Flexible elastomeric article with enhanced lubricity
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
CA2457251A1 (en) Smoking articles and smokable filler materials therefor
CA2337015A1 (en) Excipient
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
AU2001246339A1 (en) Lyophilized powder of lentinan and the process of preparation thereof
AU3388997A (en) Inhaler apparatus with modified surfaces for enhanced release of dry powders
AU2033595A (en) Cefixime composition
WO2000037546A3 (de) Expandierte polypropylen-partikel
MX9702597A (es) Aspartame sobre un soporte.
WO2003013987A3 (en) Flight for a conveyor
WO1996004219A3 (en) Manufacture of ceramic articles
SE9701278L (sv) Pulverformigt biogent, av förbenade hjort framställt preparat och på det biogena preparatet baserad livsmedelstillsats
JPS578280A (en) Aerosol suspension
CA2241039A1 (en) Insulating construction material
WO2002002082A3 (de) Verwendung von dicalciumphosphatanhydrid-pulver